APA (7th ed.) Citation

Teerat Sawangpanyangkura, Panwadee Bandhaya, Pattanin Montreekachon, Anongwee Leewananthawet, Arintaya Phrommintikul, Nipon Chattipakorn, & Siriporn C. Chattipakorn. (2022). The elevation of fibroblast growth factor 21 is associated with generalized periodontitis in patients with treated metabolic syndrome. BMC.

Chicago Style (17th ed.) Citation

Teerat Sawangpanyangkura, Panwadee Bandhaya, Pattanin Montreekachon, Anongwee Leewananthawet, Arintaya Phrommintikul, Nipon Chattipakorn, and Siriporn C. Chattipakorn. The Elevation of Fibroblast Growth Factor 21 Is Associated with Generalized Periodontitis in Patients with Treated Metabolic Syndrome. BMC, 2022.

MLA (9th ed.) Citation

Teerat Sawangpanyangkura, et al. The Elevation of Fibroblast Growth Factor 21 Is Associated with Generalized Periodontitis in Patients with Treated Metabolic Syndrome. BMC, 2022.